-
How did this happen? asks the woman sitting in your office as you share the news from the pregnancy test. I was using birth control.
-
A 13-year-old female sits in your exam room. On her initial gynecologic exam at age 12, she did not indicate that she was sexually active.
-
Expect more questions from patients about hormone therapy (HT) with the publication of three reports from the Womens Health Initiative (WHI), the largest randomized controlled trial conducted to date on the drug therapy.
-
The push for chlamydia screening has been intensified, with the Washington, DC-based American College of Preventive Medicine (ACPM) issuing a practice policy statement calling for the annual screening of all sexually active women 25 years of age or younger, as well as sexually active women with other risk factors.
-
When it comes to the battle against HIV, its time to redouble your efforts at reducing the number of new HIV infections. Why? Reports show an increase of newly diagnosed infections during 1999-2001, which reverses a several-year decline.
-
The Food and Drug Administration (FDA) has approved a new device to be used in vasectomy procedures: the Vasclip, a small polymeric clip designed to stop the flow of sperm through the vas deferens.
-
Screen patients for HIV transmission risk
-
With forecasts of shortfalls in state revenues, stagnant federal Title X funding, and increased operating costs, what is your facility doing to combat the battle of the budget?
-
The manufacturer of a feminine hygiene product is exploring potential use of the device as a disposable diaphragm and carrier for a microbicidal gel to deliver protection against pregnancy and sexually transmitted infections (STIs), including AIDS and HIV.
-
What is your facility doing to reach out with HIV prevention messages to the Latino community? Know this: While Latinos represent approximately 14% of the U.S. population, they account for almost one-fifth (19%) of the 40,000 new HIV infections estimated to occur in the United States each year.